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A B S T R A C T
Introduction: Human exposure to persistent organic pollutants (POPs) has been linked to genitourinary health-
related conditions such as decreased sperm quality, hypospadias, and prostate cancer (PCa). Conventional risk
assessment of POPs focuses on individual compounds. However, in real life, individuals are exposed to many
compounds simultaneously. This might lead to combinatorial effects whereby the global effect of the mixture is
different from the effect of the single elements or subgroups. POP mixtures may act as endocrine disruptors via
the androgen receptor (AR) and potentially contribute to PCa development.
Aim: To determine the endocrine disrupting activity of a POP mixture and sub-mixtures based upon exposure
levels detected in a human Scandinavian population, on AR transactivation and translocation in vitro.
Materials and methods: The Total POP mixture combined 29 chemicals modelled on the exposure profile of a
Scandinavian population and 6 sub-mixtures: brominated (Br), chlorinated (Cl), Cl+ Br, perfluorinated (PFAA),
PFAA+ Br, PFAA+ Cl, ranging from 1/10× to 500× relative to what is found in human blood. Transactivation
was measured by reporter gene assay (RGA) and translocation activity was measured by high content analysis
(HCA), each using stably transfected AR model cell lines.
Results: No agonist activity in terms of transactivation and translocation was detected for any POP mixtures. In
the presence of testosterone the Cl+ Br mixture at 100× and 500× blood level antagonised AR transactivation,
whereas the PFAA mixture at blood level increased AR transactivation (P < 0.05). In the presence of testos-
terone the Cl and PFAA + Br mixtures at 1/10×, 1×, and 50× blood level antagonised AR translocation
(P < 0.05).
Conclusion: Taken together, some combinations of POP mixtures can interfere with AR translocation. However,
in the transactivation assay, these combinations did not affect gene transactivation. Other POP combinations
were identified here as modulators of AR-induced gene transactivation without affecting AR translocation. Thus,
to fully evaluate the effect of environmental toxins on AR signalling, both types of assays need to be applied.
1. Introduction
Man-made chemicals are a part of everyday life and some may
mimic hormonal signalling in humans. These exogenous substances or
mixtures, called endocrine disrupting chemicals (EDCs), alter the
function of the endocrine system, subsequently causing adverse health
effects (IPCS, 2012). Persistent organic pollutants (POPs) are a class of
chemicals that remain in the environment for prolonged periods of time
due to their structural resistance to conventional processes of de-
gradations leading to bioaccumulation and bioamplification in those
exposed. Consequently, elimination half-lives range from days to dec-
ades (Bu et al., 2015; Lee et al., 2014; Trudel et al., 2011; New Jersey
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Drinking Water Quality Institute Health Effects Subcommittee, 2015;
Butt et al., 2007; Li et al., 2018; Olsen et al., 2007; Chaparro-Ortega
et al., 2018). Recent studies have identified a number of POPs which
accumulate in blood, seminal fluid, breast milk, and umbilical cord
blood (Olsen et al., 2012; Raymer et al., 2012; Kubwabo et al., 2013;
Kim et al., 2011). POPs may also act as endocrine disruptors via ab-
normal hormonal signalling and have been linked to many health-re-
lated conditions such as developmental abnormalities, infertility, and a
number of cancers (Mamsen et al., 2017; Eke et al., 2017). Con-
ventionally POPs are investigated for their endocrine disrupting po-
tential as single compounds and may exert androgenic/anti-androgenic
effects. However, a more relevant approach to investigating POPs is by
using mixtures. Recent research demonstrates combinatorial effects of
substance mixtures representing sophisticated human-like exposure
compared to single compound investigations (Rider et al., 2008).
In the current study, POP mixtures used are based on concentrations
of relevant POPs measured in human blood, according to recent studies
of the Scandinavian population (Haug et al., 2010; Knutsen et al., 2008;
Polder et al., 2008; Polder et al., 2009; Van Oostdam et al., 2004) as
described in Table 1 (Berntsen et al., 2017). This novel POP mixture
contains a total of 29 compounds which are chlorinated, brominated,
and perfluorinated. In addition to the Total mixture which contains all
29 compounds, there were a number of sub-mixtures synthesised: a
chlorinated (Cl) mixture, brominated (Br) mixture, perfluorinated
(PFAA) mixture, chlorinated + brominated (Cl+ Br) mixture, per-
fluorinated + brominated (PFAA + Br) mixture perfluorinated +
chlorinated (PFAA + Cl) mixture. The design of an environmentally-
relevant POP mixture allows for new data to be generated that tests the
combined effect of multiple mixtures added together when exposed to
cells in vitro. This study will assess the transactivation and transloca-
tion effect of a Total POP mixture and the sub-mixtures on the androgen
receptor (AR).
Biologically, exposure to substances or mixtures which perturb the
androgen signalling axis has previously been shown to induce geni-
tourinary complications in rodent models in addition to reduced sperm
quality (Ge et al., 2018; Sengupta and Banerjee, 2014). Mechanistically,
(anti-) androgenic effects may be mediated at several phenotypic levels
and as such there are vastly different (anti-) androgenic experimental
endpoints including genetic and epigenetic, transcriptomic, proteomic,
cellular, and tissue level. Nevertheless, while the chosen experimental
endpoints may depend on the research question being asked, andro-
genic and anti-androgenic effects are executed molecularly via the an-
drogen receptor (AR). Over-stimulation or dysregulation of AR signal-
ling may lead to adverse health effects such as genitourinary
complications or even PCa (Yamabe et al., 2000). The focus of this
study will be AR-mediated endocrine disruption, specifically AR
transactivation and translocation, using pre-clinical cell models.
In normal physiological conditions the AR is continuously under-
going nucleocytoplasmic shuttling and the localisation of the nuclear
receptor is determined by the accessibility of the nuclear localisation
signal (Guiochon-Mantel et al., 1996; Pratt et al., 1999). Upon ligand
binding the AR is transported to the cell nucleus via the classical import
receptors, importin-α and β. Upon entry to the nucleus, the GTPase
protein Ran, dissociates the AR from importin receptors allowing for
them to be recycled and to continue shuttling additional AR proteins
(Cutress et al., 2008). Within the nucleus, AR homodimers are func-
tional transcription factors with the DNA binding domains consisting of
zinc finger motifs to allow for recognition of AR target genes. Fur-
thermore, amino acids of the zinc finger motifs contain the nuclear
localisation signal and its location is dependent on the availability of
androgens (Jenster et al., 1993; Zhou et al., 1994).
POPs, such as those used in this study, have come under scrutiny
due to their suspected endocrine disrupting potential via AR signalling.
Typically, POPs are tested for their endocrine disrupting potential using
transactivation-based assays by analysing nuclear receptor transacti-
vation change upon exposure to a range of potential EDCs. However,
this model is too simple as there are upstream events to consider that do
not always result in the transactivation of a reporter gene. High content
analysis (HCA) allows for the generation of high throughput data spe-
cific to single and multiple cell events simultaneously and is a valuable
tool for the phenotypic screening of POPs in vitro. Previous work car-
ried out has utilised the same POP mixtures to show the effect on
glucocorticoid receptor (GR) translocation in stably transfected GR U-2
OS cells (Wilson et al., 2016a), however, the concentration range tested
were significantly greater and thus not as relevant to human exposure
levels. In the current study, HCA will determine if POP mixtures mod-
ulate AR translocation activity. Combining these data with the AR
transactivation assay will allow for the determination of whether spe-
cific POP mixtures induce agonist or antagonist effects on one or two
aspects of AR signalling.
The aim of the current study is to determine endocrine disrupting
effects of a novel human exposure based POP mixture and sub-mixtures
on AR transactivation and AR translocation. Additionally, this study
aims to differentiate POP mixtures by dissecting AR action into AR
translocation and AR transactivation. This will elucidate potential new
biological pathways which may be used to determine a new mechanism
of action for potential EDCs which historically would be overlooked
based upon a transactivation-based assay. Lastly, the aim is to
Table 1
The total in vitro mixture containing 29 different POP-based on human blood
levels. For μM concentrations the estimated concentration of POPs in the Total,
Cl, PFAA + Cl and Cl+Br stock solutions are 1,000,000 times the estimated
concentrations in human blood, in comparison with the PFAA, Br and PFAA +
Br stock solutions where the estimated concentration of POPs are 10,000,000
times the estimated concentrations in human serum.
Compound Average human
blood levelsa
ng/g lipid
Average human
blood levelsb
ng/ml
Total mixture stock
measured concentrationc
μM
PCB 28 2.13 0.013 31.1
PCB 52 1.60 0.010 20.5
PCB 101 1.30 0.008 24.5
PCB 118 10.67 0.064 137.9
PCB 138 37.00 0.222 429.5
PCB 153 60.33 0.362 698.3
PCB 180 32.33 0.194 339.0
∑ PCBs 145.36 0.873 1680.8
p,p′-DDE 83.67 0.502 1065.9
HCB 19.50 0.117 228.2
α-Chlordane 1.80 0.011 23.7
Oxychlordane 3.70 0.022 33.0
trans-Nonachlor 6.80 0.041 99.1
α-HCH 1.00 0.006 16.8
β-HCH 8.77 0.053 75.6
γ-HCH (Lindane) 1.00 0.006 16.8
Dieldrin 4.00 0.024 56.2
PBDE 47 1.43 0.009 17.8
PBDE 99 0.59 0.004 7.5
PBDE 100 0.36 0.002 3.8
PBDE 153 1.64 0.010 2.1
PBDE 154 0.29 0.002 3.0
PBDE 209 1.81 0.011 9.4
HBCD 4.10 0.025 54.5
PFHxS N/A 3.450 7809.2
PFOS N/A 29.425 41,522.1
PFOA N/A 4.523 4209.4
PFNA N/A 0.800 1092.5
PFDA N/A 0.495 375.4
PFUnDA N/A 0.560 336.8
For full table and description see reference (Berntsen et al., 2017).
a Average human blood levels of POPs based on a literature review of
Scandinavian values, providing the basis for the in vitro mixture.
b Average human blood levels of POPs converted to ng/ml. A fat percentage
of 0.6% was used. 1ml blood was considered to have a weight of 1 g.
c Measured concentrations of the various compounds in the total mixture
stock converted to μM.
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determine if a Total POP mixture exerts an endocrine disrupting effect,
on AR signalling, and additionally investigate if this effect is masked,
inhibited, or enhanced with individual sub-mixtures.
2. Materials and methods
2.1. Reagents
Cell culture reagents (fetal bovine serum, charcoal-stripped fetal
bovine serum, penicillin streptomycin, DMEM Glutamax™, L-glutamine,
and G418) were supplied by Life Technologies (Paisley, UK).
Testosterone, phosphate buffered saline (PBS), dimethyl sulfoxide
(DMSO), and MTT powder was purchased from Sigma-Aldrich (Poole,
Dorset, UK). The luciferase reporter gene assay kit (containing luci-
ferase buffer and lyophilised luciferase substrate) and a 5× cell lysis
reagent was purchased from Promega (Southampton, UK). Hoechst
33342 was purchased from Thermo Scientific (UK).
2.2. Chemical mixtures
The mixtures of POPs used in the current studies were obtained
from the Norwegian University of Life Sciences, Oslo (Prof. E. Ropstad).
Conceptually, the mixtures were designed to be chemically defined
with regards to composition, and using concentrations ratios reflecting
human exposure levels. A detailed description of the design can be
found in the Berntsen et al. (2017) manuscript and supplementary
material therein. In short, the total mixture contains 29 different POPs
at concentrations of relevant POPs measured in human blood, as
overviewed in Table 1. Additional information on sources and purity of
the individual chemicals is given in Supplementary material 1. In ad-
dition to the total mixture, containing all the test compounds, sub-
mixtures were constructed based on individual classes of POPs: a mix-
ture containing i) the perfluorinated alkyl agents (PFAA mixture), ii)
brominated flame retardants (Br mixture), iii) PCB and organochlorine
pesticides (Cl mixture). Combinations of these sub-mixtures were also
created: PFAA + Br mixture, PFAA + Cl mixture, Br+Cl mixture. A
full overview of these mixtures is given in Table S9 in Berntsen et al.
(2016). All stocks were created in DMSO at concentrations equivalent
to 1,000,000× human blood concentrations for the total mixture, Cl
mixture, and all combinations with the Cl mixture. The PFAA mixture,
the Br mixture, and the PFAA + Br mixture stocks were 10 times more
concentrated, and equivalent to 10,000,000× human blood con-
centrations. Stocks were stored at −20 °C. For exposure studies in the
cell models described below, stocks were serially diluted into medium,
and tested at final concentrations equivalent to 1/10×, 1×, 50×,
100×, 500× relative to blood levels. Final DMSO concentration was
0.2% and was kept constant in all dilutions tested.
2.3. Cell culture
All cells were routinely cultured in 75 cm2 tissue culture flasks
(Nunc, Roskilde, Denmark) at 37 °C with 5% CO2 and 95% humidity.
2.3.1. TARM-Luc cells
TARM-Luc cells were obtained from the University of Liege (Dr
Marc Muller) and previously generated by Willemsen et al. (2004).
Briefly, T47D (ATCC HTB-133) cells were obtained from ATCC (Man-
assas, VA, USA). T47D cells were grown in DMEM medium supple-
mented with 10% heat-inactivated fetal calf serum (FCS), penicillin G
(100 UmL−1), streptomycin (100 μgml−1) amphotericin B, and
1 μgml−1 bovine pancreas insulin.
For stable transfection T47D were seeded at approximately 70%
confluency in a 60-mm culture dish. The next day cells were transfected
with 2 μg MMTV-Luc and 0.2 μg pCDNA6/V5-His (Invitrogen), using
Lipofectamine Plus (Life Technologies). The next day cells were in-
oculated into three 150-mm culture dishes for clone isolation. Cells
were selected with 5 μgmL−1 blasticidin (Invitrogen) and the medium
was changed every 3–4 days. After 3 weeks visible clones were propa-
gated into 24 well plates and tested for DHT (Sigma)-induced luciferase
expression. To generate the TARM-Luc cell line, which is androgen
responsive, the MMTV-Luc-containing TM-Luc line was transfected with
the pSV-AR0 expression vector (provided by A. Brinkmann, Rotterdam,
Netherlands) and the pcDNA3 selection vector for geneticin resistance
(Invitrogen). Clone selection was performed using G418 (Life
Technologies) in the medium. In the present study, TARM-Luc cells
were cultured in DMEM Glutamax™ supplemented with 10% foetal
bovine serum (FBS). For seeding and exposures TARM-Luc cells were
cultured in DMEM Glutamax™ supplemented with 10% charcoal-
stripped (CCS)-FBS.
2.3.2. Recombinant AR U-2 OS cells
Recombinant U-2 OS cells with an AR (GenBank Acc. NM_000044)
coding sequence (AR U-2 OS) fused to the C-terminus of an enhanced
green fluorescent protein (EGFP) stably integrated onto the human
osteosarcoma U-2 OS line (ATCC® HTB-96™) were purchased from
Thermo Scientific, USA (catalogue number R04-043-01). Cells were
cultured in DMEM Glutamax™ supplemented with 10% FBS, 1% peni-
cillin-streptomycin (P/S), 2 mM L-Glutamine, and 0.5mg/ml G418
sulphate Cells were seeded in DMEM Glutamax™ supplemented with
10% CCS-FBS, 1% P/S, 2mM L-Glutamine, and 0.5mg/ml G418 sul-
phate. For exposure cells were cultured in DMEM Glutamax™ supple-
mented with 1% P/S, and 2mM L-Glutamine.
2.4. Reporter gene assay
The androgen receptor Reporter gene assay (RGA) was carried out
as previously described (Frizzell et al., 2011). Briefly, TARM-Luc cells
were seeded 40,000 cells per well in specialised white-walled, clear flat-
bottomed 96 well plates (Greiner, Bio-One, Frickenhausen, Germany).
Plates were incubated at 37 °C with 5% CO2 overnight. Subsequently
cells were exposed to POP mixtures in the presence of the solvent
control (SC; 0.2% DMSO, v:v in media, uniformly maintained across all
samples) at 1/10×, 1×, 50×, 100×, and 500× relative to blood level
for the agonist test. A standard curve of 0.1–1000 nM testosterone was
generated (Supplementary material 2) and agonist test responses were
analysed relatively. For the antagonist test, testosterone (50 nM) was
used as the positive control (PC; a concentration which corresponds to
EC64 on the standard curve) and each POP mixture was combined with
the PC at 1/10×, 1×, 50×, 100×, and 500× relative to blood level.
Thus allowing for both synergistic and antagonist responses. Cells were
exposed for 48 h. The supernatant was discarded and the cells washed
twice with phosphate buffered saline (PBS) prior to lysis with 1× cell
lysis reagent (Promega, Southamton, UK) used according to manufac-
turer's instructions, facilitated by agitation. Plates were then read using
a Mithras Multimode Reader (Berthold, Other, Germany) which in-
jected each well with 100 μl of luciferase substrate buffer from luci-
ferase reporter gene assay kit (Promega, Southampton, UK), used ac-
cording to manufacturer's instructions, and measured the response of
each well via detection of luminescence. TARM-Luc cells upon AR
transactivation express a luciferase signalling protein allowing for the
detection of both agonist and antagonist responses which were com-
pared to the SC (0.2% DMSO in media) and PC (50 nM testosterone in
media) respectively.
2.5. MTT assay
TARM-Luc cells were seeded in clear flat-bottomed 96-well plates
(Nunc, Roskilde, Denmark) and followed the same seeding and ex-
posure protocol as described for the RGA. After 48 h of exposure, the
supernatant was then discarded and the cells washed once with PBS.
Cells were then incubated for 3 h with 2mg/ml thiazolyl blue tetra-
zolium bromide (MTT) (Sigma-Aldrich, St Louis, MO, USA) solution
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diluted 1:6 in assay media. Healthy cells convert soluble yellow MTT
solution to insoluble purple formazan crystals. The supernatant was
removed and 200 μl solution of DMSO added to dissolve the formazan
crystals during a 10min incubation with agitation at 37 °C. Optical
density was measured at 570 nm with a reference filter at 630 nm using
a Sunrise spectrophotometer (TECAN, Switzerland). Metabolic activity
was calculated as a percentage absorbance of the sample compared
with the absorbance of the solvent control. Metabolic activity was used
as an indirect measure of gross cytotoxicity.
2.6. High content analysis
Recombinant AR U-2 OS cells were prepared by seeding 6000 cells
per well in black walled 96 well plates with clear flat bottoms (Greiner,
Germany). Plates were incubated at 37 °C 5% CO2 overnight.
Subsequently cells were exposed as described above with the relevant
SC (0.2% DMSO) and PC (50 nM testosterone). After 6 h of exposure
cells were washed with 1× PBS and fixed using 5% formalin. Cells were
then washed twice with 1× PBS and subsequently stained using 2 μM
Hoechst 33342. Plates were read using CellInsight NXT High Content
Analysis Platform (ThermoFisher Scientific, UK) using Spot Detector
bioapplication which measures the translocation activity of the AR. For
the agonist test responses were assessed against a testosterone standard
curve (0.1–100 nM) and for antagonist testing responses were measured
against the PC (50 nM testosterone) which was the same as that used for
the RGA.
Recombinant AR U-2 OS cells express a stably-transfected androgen
receptor fused with an enhanced GFP. A wavelength of 485 nm was
used to detect EGFP-AR localisation upon successful ligand binding to
androgen response elements (AREs, Fig. 1). The primary channel 2
output was spot count per object;
Spotcountperobject = totalnumberofspots EGFP AR
÷ nuclear (cell) number
( )
Hoechst 33342 was used to counter stain cell nuclei in each well. A
wavelength of 386 nm was used to detect binding of Hoechst 33342 to
nuclei. Output parameters included; object count (cell number), nuclear
area, and nuclear intensity. The HCA platform measures the binding of
Hoechst 33342 to cell nuclei. The platform refers to one cell nucleus as
an object. Cell nuclei and object count are interchangeable; object
count is a measure of cell number. Cell nuclei are validated based upon
circularity, size, and intensity of fluorescence. Therefore, a reduction in
object count (cell number) reflects gross cellular toxicity induced by
POP mixtures. A decreased nuclear (object) area combined with in-
creased nuclear intensity is indicative of an apoptotic programme
taking place in cells.
2.7. Statistical analysis
All experiments were carried out in triplicate and in three in-
dependent exposures. Data was analysed using Microsoft Excel in ad-
dition to Graphpad PRISM software, version 5.01 (San Diego, CA).
Values are expressed as the mean of 9 triplicates from the 3 in-
dependent exposures± standard error of the mean (SEM). Data is ex-
pressed as a percentage of the solvent or positive controls, where ap-
plicable. Analysis carried out includes i) one-way ANOVA followed by
Fig. 1. Illustration of the AR translocation event. In unstimulated (or solvent control) recombinant AR U-2 OS cells, enhanced green fluorescent protein tagged
androgen receptor (EGFP-AR) is localised to the cytoplasm of the cells. Upon exposure to androgens such as testosterone the EGFP-AR translocates to the cell nucleus
whereby it binds to androgen response elements in the promoter/enhancer regions of target genes. The HCA platform is capable of measuring the formation of
nuclear foci. For an agonist response there is an increase in nuclear foci. Upon exposure to anti-androgens, such as the non-steroidal anti-androgen enzalutamide,
EGFP-AR may still translocate to the nucleus, however, it is prevented from binding to AREs. For an antagonist response there is a reduction in nuclear foci compared
to the positive control.
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Dunnett's procedure for multiple comparisons; the mean concentrations
were tested for significant difference at the 95% confidence level.
Significant values were as follows; P≤ 0.05 (*), P≤ 0.01 (**), and
P≤0.001 (***).
3. Results
The potential endocrine disrupting activity of an environmentally-
relevant POP mixture containing 29 compounds and sub-mixtures
thereof on AR transactivation and translocation was investigated.
3.1. Cytotoxicity and cellular health
Gross cytotoxicity was evaluated in the AR RGA cell model (TARM-
Luc) by quantifying metabolic activity using MTT conversion. Cellular
health in the AR translocation assay (recombinant AR U-2 OS) was
monitored using a HCA platform. Here, multiple parameters for pre-
lethal cytotoxicity were measured, including cell number (object count)
and nuclear morphology (nuclear area, nuclear intensity).
3.1.1. Metabolic activity of AR RGA cell model (TARM-Luc) exposed to
POP mixtures as measured by MTT conversion
The MTT assay was carried out after 48 hour exposure to the POP
mixtures as a measure of metabolic activity. No significant effects were
induced by the Total mixture on metabolic activity compared to the SC
(Fig. 2A). Non-monotonic responses for several of the sub-mixtures
were observed (Fig. 2B–H), however, the Total mixture and sub-mix-
tures did not significantly increase or decrease metabolic activity
compared to the SC (Fig. 2).
3.1.2. Evaluation of markers for pre-lethal cytotoxicity in the AR
translocation cell model (recombinant AR U-2 OS) using HCA
HCA demonstrated a number of significant findings. Object count, a
parameter for cell number, was only affected significantly by the Cl
mixture (500× relative to blood level) which decreased cell number,
when compared to the SC (Cl mixture 500×=73.2% ± 7.9 SEM vs
SC=100% ± 7.7 SEM; P < 0.05). The other POP mixtures did not
significantly impact cell number, as evaluated by object count. The Cl
mixture and PFAA + Cl mixture (both at 1×) decreased nuclear area
by 4.3% ± 1.6 SEM (P < 0.05) and 3.6% ± 0.7 SEM (P < 0.001)
respectively, when compared to the SC. The Br mixture (500×), Cl
mixture (1/10×, 1×, 50×, 100×, and 500×), PFAA mixture (100×,
and 500×), and Total mixture (1×, 100×, and 500×) all increased
nuclear intensity significantly (P < 0.05), when compared to the SC
(Fig. 3). The PFAA + Br mixture at 1/10× decreased nuclear intensity
by 4.8% ± 1 SEM (P < 0.05) when compared to the SC (Fig. 3).
3.2. Androgen receptor (AR) mediated reporter gene transactivation
At the concentrations tested (1/10×, 1×, 50×, 100×, and 500×)
none of the POP mixtures tested showed any agonist activity on AR
transactivation when compared to the SC. When screened for antag-
onism, in the presence of testosterone, the Cl+Br mixture (100× and
500× relative to blood level) antagonised AR transactivation by
21.1% ± 3.8 SEM (P < 0.05; Fig. 4Fig. 5) and 30.2% ± 5.2 SEM
(P < 0.001) respectively compared to the PC. In contrast, the PFAA
mixture at 1× relative to blood level increased AR transactivation by
17.5% ± 3.4 SEM compared to the PC alone (P < 0.05; Fig. 4Fig. 5).
3.3. Translocation of the androgen receptor in the recombinant AR U-2 OS
model
3.3.1. Agonism and antagonism of AR translocation by POP mixtures in the
recombinant AR U-2 OS model evaluated by HCA
At the concentrations tested (1/10×, 1×, 50×, 100×, and 500×)
none of the POP mixtures tested showed any agonist activity on AR
translocation when compared to the SC. When all the mixtures where
tested in the presence of testosterone, only Cl and PFAA + Br mixtures
significantly antagonised AR translocation activity at 1/10×, 1×, and
50×. The Cl mixture antagonised AR translocation by 28.5% ± 5.1
SEM (P < 0.01), 24.5% ± 2.4 SEM (P < 0.05), and 25.4% ± 6.1
SEM (P < 0.05), respectively for 1/10×, 1×, and 50× relative to
blood level when compared to the PC (Fig. 5). The PFAA + Br mixture
antagonised AR translocation by 34.8% ± 6.9 SEM (P < 0.001),
27.6% ± 7.1 SEM (P < 0.01), and 24.2% ± 6.5 SEM (P < 0.05)
respectively for 1/10×, 1×, and 50× relative to blood level when
compared to the PC (Fig. 5).
4. Discussion
This study evaluated human exposure-based POP mixtures with
respect to their potential effect on AR-mediated gene transactivation
and AR receptor translocation using in vitro cell models.
Cytotoxicity and cellular health data is important to consider for
cellular assays, as the functional AR-related read-outs (transactivation
and translocation) used in this study, depend on normal physiological
and molecular functioning of the cells. A combined interpretation of the
observations, whether by MTT (Fig. 2) or HCA (Fig. 3), indicates that
none of the mixtures is grossly cytotoxic at any of the concentrations
tested. However, assessing antagonism in the RGA by a single gross
cytotoxic or cell viability endpoint such as MTT is a limitation of this
study as even subtle effects in cellular health (not detected by MTT) can
influence antagonism measurements, more so than agonism. For pre-
lethal cytotoxicity markers, although significant changes in nuclear
parameters were observed for many of the mixtures at given con-
centrations, the absolute changes are small, and the biological sig-
nificance with regards to cell viability might be limited, as no clear
dose-response relationships are seen.
Transactivation based assays are widely utilised for establishing
endocrine disrupting activity of potential EDCs (Frizzell et al., 2011). In
recent papers, it has been reported that individual compounds within
the current mixture are agonists or antagonists of the AR (Table 2).
However, the issue with these studies is the test concentrations used to
exert an effect. For example, PCB 52 was shown to antagonise AR
transactivation activity at 3.2 μM (Takeuchi et al., 2017), yet in the
current mixture, based upon human blood levels, PCB 52 is only found
at 20.5 pM. AR disrupting effects can thus only result from the presence
of many individual compounds within (sub-) mixtures reported to exert
an effect on AR transactivation. The current study demonstrates that, in
the presence of testosterone, the Cl+Br mixture (both 100× and
500×) antagonise AR transactivation, whereas the PFAA mixture (1×)
increases AR transactivation (Fig. 4). To validate these results, cyto-
toxicity analysis, as determined by MTT, carried out concomitantly
with the RGA demonstrated no changes in metabolic activity for these
mixtures. The results of this study are unique from previous studies as
the concentration range tested was based upon a realistic mixture ob-
served in an actual human population (1×) and cover a range relevant
to differing population exposure levels (i.e. 1/10× for those rarely
exposed to 500× for occupational exposure). Therefore, the current
study provides an exposure model relevant to human health.
In addition to measuring AR-mediated transactivation in response to
POP mixtures, the present study utilised a HCA platform for analysing
the endocrine disrupting effect of these mixtures via AR translocation
using stably transfected AR model cell lines (recombinant AR U-2 OS).
The HCA platform is a powerful tool allowing for the identification of
translocation changes of the AR. Our HCA results in recombinant AR U-
2 OS cells revealed that the Cl and PFAA + Br mixtures (both at 1/
10×, 1×, and 50×) significantly antagonised AR translocation ac-
tivity. In a recent study the same POP mixtures were used (Wilson et al.,
2016b), however, exposure levels ranged from 500× to 10,000× re-
lative to human blood level, consistent with the current findings that no
effect is observed at concentrations higher than 50×. This is the first
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study to report findings based upon actual human exposure levels in the
context of the AR.
Results observed in this study (Fig. 6) are important as the data
suggests that some mixtures may not exert an agonist or antagonist
effect yet when combined with another mixture may in fact potentiate
endocrine disrupting effects in terms of AR transactivation. This was the
case for the Br and Cl individual mixtures. Individually, these mixtures
did not significantly increase (agonist) or decrease (antagonist) AR
transactivation activity, however, when combined to form the Cl+ Br
mixture an antagonistic effect was seen. Similarly, this was the case for
the PFAA and Br mixtures as determined by HCA. The PFAA and Br
mixtures did not impact AR translocation activity, yet when combined
together to form the PFAA + Br mix there was an antagonist response
seen in AR translocation (Fig. 5A). Conversely, results also demonstrate
that while individual mixtures exert an antagonist effect, the effect may
be lost when combining the mixture with another mixture. This was
observed by HCA as the Cl mixture antagonised AR translocation
(Fig. 5A), yet when combined with the PFAA mix to form the PFAA +
Cl mix no effect was seen. Recent studies have similarly demonstrated
evidence of the cocktail effect and indeed lack of an effect of an overall
mixture where the parts have known endocrine disrupting properties.
At low nanomolar concentrations HCB, p,p′-DDE, PCB, PFOA, and PFOS
(all of which are contained in the current total mixture) exerted a mi-
togenic effect in vitro; while the total mixture did still exert a pro-
liferative effect the observed effect was lower than predicted (Gogola
et al., 2019). Furthermore, a 1/10× and 1× mixture induced a greater
Fig. 2. The metabolic effect of 48 hour exposure to POP mixtures in the TARM-Luc androgen receptor gene assay cell line. Despite some minor increases and
decreases in metabolic activity (measured by the MTT assay) the Total POP mixture and the sub-mixtures were not directly toxic to RGA model cell line TARM-Luc.
Results are representative of 3 independent exposures (n= 3, mean ± SEM).
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mitogenic effect than the 10× mixture (Gogola et al., 2019). This
pattern of low level exposure is similarly displayed in our results with
1/10×, 1×, and 50× mixtures antagonising AR translocation, yet the
same mixtures at 100× and 500× did not. In another study, a mixture
of PFAAs (the same as those used in the current study- but at much
higher concentrations) demonstrated a higher than additive effect by
antagonising AR transactivation (Kjeldsen and Bonefeld-Jorgensen,
2013).
Receptor transactivation assays are well established within endo-
crine disruptor testing regimes (Frizzell et al., 2011; Takeuchi et al.,
2017; Schrader and Cooke, 2000; Schrader and Cooke, 2003). Trans-
location is a sub-component of AR gene regulation and is taken for
granted in transactivation-based assays. However, the monitoring of
translocation is not a widely used assay in the area of endocrine dis-
ruptor testing.
We hypothesised that compounds which elicit androgenic effects in
vivo but do not disrupt receptor transactivation may be acting as en-
docrine disruptors via another pathway, specifically disruption of re-
ceptor translocation. Therefore, we tested the effects of the POP mix-
tures on both receptor transactivation using RGA and translocation
using HCA. Our results demonstrate that Cl and PFAA + Br mixtures at
multiple concentrations (1/10×, 1×, and 50×) can disrupt androgen
receptor signalling at the level of receptor translocation but not impact
upon AR-mediated gene transactivation as determined by RGA. This is
important as the AR is responsible for the transcriptional regulation of
many different genes across the genome (which cannot be assessed by
RGA). As such, the AR translocates and binds to specific DNA regions
(androgen response elements) in the promoter region of target genes.
While our HCA assay cannot identify specific changes in these binding
sites, it does in fact serve as a valuable screening tool that will indicate
whether the total number of DNA-bound AR is increased (agonist) or
decreased (antagonised). To our knowledge we are the first group to
investigate AR disruption to this level of scrutiny, including transacti-
vation and translocation.
A recent in vivo study demonstrated anti-androgenic effects (de-
creased testicular weight) following exposure to PCBs, while another
associated exposure to p,p′-DDE with decreased ano-genital distance in
first-trimester boys (Persson and Magnusson, 2015; Torres-Sanchez
et al., 2008). In the current study the Cl mixture (including PCBs) at 1/
10×, 1×, and 50× antagonised AR translocation but not transacti-
vation. Therefore, it is possible that the anti-androgenic effect is elicited
via AR translocation but this would be missed in transactivation assays.
Furthermore, there are conflicting reports as to whether PFAAs antag-
onise AR transactivation (Kjeldsen and Bonefeld-Jorgensen, 2013; Du
et al., 2013). This addresses the need for more cutting edge molecular
biology assays to elucidate the mechanism of action of potential en-
docrine disrupting chemicals that do not act via the classical AR
transactivation pathway and our HCA system is capable of screening
Fig. 3. Pre-lethal cytotoxicity markers in the AR U-2 OS cell line following 6 hour exposure to POP mixtures as assessed by high content analysis. A. Changes in object
count in response to POP mixtures compared to SC. B. Changes in nuclear area in response to POP mixtures compared to SC. C. Changes in nuclear intensity in
response to POP mixtures compared to SC. Results are representative of 3 independent exposures (n= 3, mean ± SEM). *=P < 0.05; **= P < 0.01;
***= P < 0.001. Only significant results are presented for nuclear intensity parameter.
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such chemicals.
The discrepancy between the RGA and HCA analysis requires fur-
ther investigation. While it is conceivable that a mixture would have no
effect on AR translocation, but interfere with transactivation at a later
step (as seen for the PFAA and Cl+ Br mixtures, Fig. 4), it is indeed
more difficult to understand how a specific mixture could inhibit AR
translocation without affecting transactivation mediated by this re-
ceptor. It is important to note that the two tests are performed in dif-
ferent cell lines, one a human mammary gland tumour cells, the other a
human osteosarcoma cell. The two cell types may present different sets
of intracellular protein kinases, translocation complexes, or other re-
ceptors. According to the ThermoFisher manual (043-01.03_AR_-
RAP_LC06613402), translocation of EGFP-AR in recombinant AR U-2
OS cells in the present of agonists leads to the formation of nuclear foci,
while antagonists leads to a more uniform nuclear distribution (Marcelli
et al., 2006), presumably due to the absence of successful AR-DNA
binding. Also, recombinant AR U-2 OS cells express the endogenous
human androgen receptor (hAR) and, furthermore it was shown that
incubation with testosterone further induces hAR transcription in these
cells (Grad et al., 2001). In contrast, the T47D parent line for the TARM-
Luc cells did not express a functional endogenous hAR (Willemsen
et al., 2004), therefore a functional AR placed under the control of a
SV40 constitutive enhancer was integrated in the TARM-Luc cell
genome. It is thus conceivable that, in the conditions of our translo-
cation antagonist tests, the testosterone present induces expression of
the endogenous hAR in the recombinant AR U-2 OS cells that would
Table 2
Reported AR effects of individual POPs contained in the human exposure-based mixture.
Compound AR agonist (μM) AR antagonist (μM) POP mixturea (pM) Referenceb
1 PCB 28 0.76 31.1 (Hamers et al., 2011)
2 PCB 52 3.2 20.5 (Takeuchi et al., 2017)
3 PCB 101 1.4 24.5 (Takeuchi et al., 2017)
4 PCB 118 0.47 137.9 (Hamers et al., 2011)
5 PCB 138 1 429.5 (Hamers et al., 2011)
6 PCB 153 1/8.5 698.3 (Takeuchi et al., 2017; Hamers et al., 2011)
7 PCB 180 2.1 339 (Hamers et al., 2011)
8 p,p′-DDE 100 0.613 1065.9 (Schrader and Cooke, 2000; Xu et al., 2006)
9 HCB 0.0005–0.005 > 10 228.2 (Ralph et al., 2003)
10 α-Chlordane 23.7
11 Oxychlordane No 33 (Schrader and Cooke, 2000)
12 Trans-nonachlor No 99.1 (Schrader and Cooke, 2000)
13 α-HCH 10 16.8 (Schrader and Cooke, 2000)
14 β-HCH No 75.6 (Schrader and Cooke, 2000)
15 γ-HCH (Lindane) No 16.8 (Schrader and Cooke, 2000)
16 Dieldrin 20 56.2 (Andersen et al., 2002)
17 PBDE 47 Yes 1.78 (Ren and Guo, 2013)
18 PBDE 99 Yes 0.75 (Ren and Guo, 2013)
19 PBDE 100 1 0.38 (Ren and Guo, 2013; Stoker et al., 2005)
20 PBDE 153 Yes 0.21 (Ren and Guo, 2013)
21 PBDE 154 No 0.3 (Stoker et al., 2005)
22 PBDE 209 0.94
23 HBCD 0.1–10+DHT 5.45 (Christen et al., 2010)
24 PFHxS 19 780.92 (Kjeldsen and Bonefeld-Jorgensen, 2013)
25 PFOS 3.2 4152.21 (Kjeldsen and Bonefeld-Jorgensen, 2013)
26 PFOA 9.6 420.94 (Kjeldsen and Bonefeld-Jorgensen, 2013)
27 PFNA 44 109.25 (Kjeldsen and Bonefeld-Jorgensen, 2013)
28 PFDA 24 37.54 (Kjeldsen and Bonefeld-Jorgensen, 2013)
29 PFUnDA No 33.68 (Kjeldsen and Bonefeld-Jorgensen, 2013)
a Concentrations (picomolar) listed in this column are the individual compound concentrations contain within the mixture (1× blood level) based upon a
Scandinavian population (Berntsen et al., 2017).
b References correlate to AR agonist and AR antagonist columns which contain the micromolar concentrations of individual POPs within known AR effects as
reported in the literature.
Fig. 4. Transactivation effects of 48 hour exposure to POP
mixtures in the TARM-Luc androgen receptor reporter gene
assay cell line. Analysing AR transactivation following ex-
posure to POP mixtures + PC compared to the PC alone.
Results are representative of 3 independent exposures
(n= 3, mean ± SEM). *=P < 0.05; **= P < 0.01;
***=P < 0.001. Only significant results are presented. Full
list of results are provided in Supplementary material 2.
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compete with the EGFP-AR for the translocation machinery, thereby
rendering the test more sensitive for disruption of translocation. This
effect would not be observed in the TARM-Luc cell line, as in those cells
the AR is constitutively expressed.
Test duration, exposure time, and different timing of the primary
read-outs after beginning exposure, are additional differences between
the RGA and HCA tests. The RGA test exposure time was 48 h whereas
the HCA test was 6 h. Possibly the inhibition of translocation observed
in the HCA test is actually a retardation, which may be caught up with
in the longer exposure of TARM-Luc cells and therefore prove irrelevant
for transactivation.
Further investigations will be required to understand the molecular
basis underlying these different reactions in the two cell lines, con-
cerning both AR nuclear translocation and transactivation mechanisms,
which may allow for the identification of novel molecular pathways
underpinning specific EDCs mechanism of action that may correlate
with phenotypic changes at the cellular and tissue level.
5. Conclusion
In conclusion, the data generated in the current study raises a
number of key concerns. Firstly, transactivation-based assays, although
very useful in endocrine disrupting research, have their limitations and
as such should be used initially as a screening tool when investigating
potential endocrine disrupting chemicals. After this, more in-depth
molecular biology assays should be conducted on compounds at specific
concentrations which warrant further investigation. This is supported
by the data which shows POP mixtures which antagonised AR trans-
location activity (Cl and PFAA + Br mixtures at 1/10×, 1×, and 50×
relative to blood level) but did not mediate any AR-specific transacti-
vation antagonism. This concept is supported by recent in vivo studies
which demonstrate anti-androgenic effects following PCB exposure yet
Fig. 5. Translocation effects of 6 hour exposure to POP mixtures on the androgen receptor in HCA model cell lines. A. Analysing AR translocation activity following
exposure to POP mixtures + PC compared to the PC alone. B–G. Representative images of the antagonist test; SC (B) channel 2 filter for EGFP (i.e. AR spots), SC (C)
composite, PC (D) channel 2 filter for EGFP (i.e. AR spots), PC (E) composite, Cl mixture 1/10× (F) channel 2 filter for EGFP, and PFAA + Br mixture 1/10× (G)
channel 2 filter for EGFP. Results are representative of 3 independent exposures (n=3, mean ± SEM). *= P < 0.05; **= P < 0.01; ***=P < 0.001. Only
significant results are presented. Scale bars= 100 μm. Full list of results are provided in Supplementary material 3. Additional images are provided in Supplementary
material 4.
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in the current study did not antagonise AR transactivation. Therefore,
without the use of HCA the Cl and PFAA + Br mixtures at 1/10×, 1×,
and 50× would have not been detected as endocrine disruptors of AR
signalling. Secondly, the data demonstrates that where POP mixtures
exert an endocrine disrupting effect (antagonism), the effect may be lost
in a Total mixture or sub-mixtures; for example, this was the case for
the Cl mixture which antagonised AR translocation activity at 1/10×,
1×, and 50× yet in the Total, Cl+ Br, and PFAA + Cl mixtures no
antagonism was detected, thus the individual effect of the Cl mixture
was lost. Thirdly, the data provided evidence of the cocktail effect;
individual compounds and/or mixtures may not exert an endocrine
disrupting effect, yet the combinatorial effect of specific mixtures may
result in an endocrine disrupting effect. This was the case for the Br and
Cl mixtures in the RGA which individually did not antagonise AR
transactivation, yet together the Cl+Br mixture antagonised AR
transactivation significantly. Similarly, in the HCA the PFAA and Br
mixtures did not antagonise AR translocation activity, yet together the
PFAA + Br mixture antagonised AR translocation activity significantly.
Lastly, interestingly, the data shows that new emerging POPs, such as
those within the PFAA mixture, have the ability to dysregulate AR
signalling. This was evident in the RGA whereby in the presence of
testosterone the PFAA mixture at blood level increased AR transacti-
vation to levels higher than testosterone alone. Assessing individual
compounds of this mixture at the relevant concentration would be a
worthwhile investigation in future studies. In conclusion the current
study uses human exposed based POP mixtures at blood-based con-
centrations and demonstrates evidence of endocrine disruption via AR
transactivation and translocation.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.envint.2019.105083.
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